Preliminary Efficacy And Safety Of Rilvegostomig (Azd2936), A Bispecific Antibody Targeting Pd-1 And Tigit, In Checkpoint Inhibitor (Cpi)-Pretreated Advanced/Metastatic Non-Small-Cell Lung Cancer (Nsclc): Artemide-01
AZD-2936
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Preliminary Efficacy And Safety Of Rilvegostomig (Azd2936), A Bispecific Antibody Targeting Pd-1 And Tigit, In Checkpoint Inhibitor (Cpi)-Pretreated Advanced/Metastatic Non-Small-Cell Lung Cancer (Nsclc): Artemide-01 ### Output: AZD-2936